☰

Michael Starr - Publications

Affiliations: 
London School of Pharmacy, London, England, United Kingdom 
Area:
Parkinson's disease, Glutamate, Dopamine
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

60 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2000 Fisher A, Starr MS. Opposite effects of glutamate antagonists and antiparkinsonian drugs on the activities of DOPA decarboxylase and 5-HTP decarboxylase in the rat brain. Brain Research. 868: 268-74. PMID 10854579 DOI: 10.1016/S0006-8993(00)02339-8  0.366
2000 Fisher A, Biggs CS, Eradiri O, Starr MS. Dual effects of L-3,4-dihydroxyphenylalanine on aromatic L-amino acid decarboxylase, dopamine release and motor stimulation in the reserpine-treated rat: evidence that behaviour is dopamine independent. Neuroscience. 95: 97-111. PMID 10619466 DOI: 10.1016/S0306-4522(99)00406-6  0.37
1999 Eradiri OL, Starr MS. Striatal dopamine depletion and behavioural sensitization induced by methamphetamine and 3-nitropropionic acid. European Journal of Pharmacology. 386: 217-26. PMID 10618473 DOI: 10.1016/S0014-2999(99)00776-1  0.377
1999 Biggs CS, Starr MS. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum. Synapse (New York, N.Y.). 34: 36-46. PMID 10459170 DOI: 10.1002/(SICI)1098-2396(199910)34:1<36::AID-SYN5>3.0.CO;2-G  0.382
1998 Fisher A, Biggs CS, Starr MS. Effects of glutamate antagonists on the activity of aromatic L-amino acid decarboxylase. Amino Acids. 14: 43-9. PMID 9871440 DOI: 10.1007/BF01345241  0.331
1998 Biggs CS, Fisher A, Starr MS. The antiparkinsonian drug budipine stimulates the activity of aromatic L-amino acid decarboxylase and enhances L-DOPA-induced dopamine release in rat substantia nigra. Synapse (New York, N.Y.). 30: 309-17. PMID 9776134 DOI: 10.1002/(SICI)1098-2396(199811)30:3<309::AID-SYN8>3.0.CO;2-F  0.359
1998 Fisher A, Biggs CS, Starr MS. Differential effects of NMDA and non-NMDA antagonists on the activity of aromatic L-amino acid decarboxylase activity in the nigrostriatal dopamine pathway of the rat. Brain Research. 792: 126-32. PMID 9593857 DOI: 10.1016/S0006-8993(98)00129-2  0.361
1997 Ozer H, Ekinci AC, Starr MS. Dopamine D1- and D2-dependent catalepsy in the rat requires functional NMDA receptors in the corpus striatum, nucleus accumbens and substantia nigra pars reticulata. Brain Research. 777: 51-9. PMID 9449412 DOI: 10.1016/S0006-8993(97)00706-3  0.41
1997 Kaur S, Ozer H, Starr M. MK 801 reverses haloperidol-induced catalepsy from both striatal and extrastriatal sites in the rat brain. European Journal of Pharmacology. 332: 153-60. PMID 9286616 DOI: 10.1016/S0014-2999(97)01078-9  0.617
1997 Biggs CS, Starr MS. Dopamine and glutamate control each other's release in the basal ganglia: a microdialysis study of the entopeduncular nucleus and substantia nigra. Neuroscience and Biobehavioral Reviews. 21: 497-504. PMID 9195608 DOI: 10.1016/S0149-7634(96)00032-2  0.358
1997 Biggs CS, Fowler LJ, Whitton PS, Starr MS. Extracellular levels of glutamate and aspartate in the entopeduncular nucleus of the rat determined by microdialysis: regulation by striatal dopamine D2 receptors via the indirect striatal output pathway? Brain Research. 753: 163-75. PMID 9125444 DOI: 10.1016/S0006-8993(97)00033-4  0.475
1997 Kaur S, Starr MS. Differential effects of intrastriatal and intranigral injections of glutamate antagonists on motor behaviour in the reserpine-treated rat. Neuroscience. 76: 345-54. PMID 9015320 DOI: 10.1016/S0306-4522(96)00407-1  0.318
1997 Starr MS, Fisher A, Biggs CS. Effects of glutamate antagonists on dopamine synthesis Amino Acids. 13: 55.  0.301
1996 Biggs CS, Fowler LJ, Whitton PS, Starr MS. NMDA receptor antagonists increase the release of dopamine in the substantia nigra of reserpine-treated rats. European Journal of Pharmacology. 299: 83-91. PMID 8901010 DOI: 10.1016/0014-2999(95)00837-3  0.399
1996 Brooks S, Kaur S, Starr BS, Starr MS. Motor actions of eliprodil in the normal and monoamine-depleted mouse: a role in the treatment of Parkinson's disease? Journal of Neural Transmission (Vienna, Austria : 1996). 103: 737-48. PMID 8836935 DOI: 10.1007/BF01271233  0.42
1996 Kaur S, Starr M. Motor effects of lamotrigine in naive and dopamine-depleted mice. European Journal of Pharmacology. 304: 1-6. PMID 8813577 DOI: 10.1016/0014-2999(96)00134-3  0.634
1996 Starr MS. The role of dopamine in epilepsy. Synapse (New York, N.Y.). 22: 159-94. PMID 8787131 DOI: 10.1002/(SICI)1098-2396(199602)22:2<159::AID-SYN8>3.0.CO;2-C  0.307
1995 Starr MS. Antiparkinsonian actions of glutamate antagonists--alone and with L-DOPA: a review of evidence and suggestions for possible mechanisms. Journal of Neural Transmission. Parkinson's Disease and Dementia Section. 10: 141-85. PMID 9620061 DOI: 10.1007/BF02251229  0.351
1995 Starr MS. Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson's disease. Synapse (New York, N.Y.). 19: 264-93. PMID 7792721 DOI: 10.1002/syn.890190405  0.341
1995 Starr MS, Starr BS. Do NMDA receptor-mediated changes in motor behaviour involve nitric oxide? European Journal of Pharmacology. 272: 211-7. PMID 7713165 DOI: 10.1016/0014-2999(94)00644-M  0.5
1995 Starr MS, Starr BS. Locomotor effects of amantadine in the mouse are not those of a typical glutamate antagonist. Journal of Neural Transmission. Parkinson's Disease and Dementia Section. 9: 31-43. PMID 7605588 DOI: 10.1007/BF02252961  0.446
1995 Kaur S, Starr MS. Antiparkinsonian action of dextromethorphan in the reserpine-treated mouse. European Journal of Pharmacology. 280: 159-66. PMID 7589181 DOI: 10.1016/0014-2999(95)00200-5  0.633
1995 Starr MS, Starr BS. Motor actions of 7-OH-DPAT in normal and reserpine-treated mice suggest involvement of both dopamine D2 and D3 receptors. European Journal of Pharmacology. 277: 151-8. PMID 7493603 DOI: 10.1016/0014-2999(95)00063-Q  0.486
1994 Alam AM, Starr MS. Effects of dopamine D3 receptor agonists on pilocarpine-induced limbic seizures in the rat. Neuroscience. 60: 1039-47. PMID 7936204 DOI: 10.1016/0306-4522(94)90281-X  0.342
1994 Alam AM, Starr MS. Bimodal effects of dopamine D2 receptor agonists on zero Mg(2+)-induced epileptiform activity in the rat cingulate cortex slice. Experimental Brain Research. 102: 75-83. PMID 7895801 DOI: 10.1007/BF00232440  0.374
1994 Kaur S, Starr MS, Starr BS. Role of D1 receptor mechanisms in the potentiation of motor responses to L-dopa and apomorphine by MK 801 in the reserpine-treated mouse. Journal of Neural Transmission. Parkinson's Disease and Dementia Section. 8: 107-16. PMID 7893372 DOI: 10.1007/BF02250921  0.423
1994 Starr MS, Starr BS. Comparison of the effects of NMDA and AMPA antagonists on the locomotor activity induced by selective D1 and D2 dopamine agonists in reserpine-treated mice. Psychopharmacology. 114: 469-76. PMID 7855205 DOI: 10.1007/BF02249338  0.438
1994 Starr MS, Starr BS. Potentiation of dopamine-dependent locomotion by clonidine in reserpine-treated mice is restricted to D2 agonists. Journal of Neural Transmission. Parkinson's Disease and Dementia Section. 7: 133-42. PMID 7710665 DOI: 10.1007/BF02260968  0.42
1993 Starr MS, Starr BS. Paradoxical facilitation of pilocarpine-induced seizures in the mouse by MK-801 and the nitric oxide synthesis inhibitor L-NAME. Pharmacology, Biochemistry, and Behavior. 45: 321-5. PMID 8327537 DOI: 10.1016/0091-3057(93)90246-P  0.351
1993 al-Tajir G, Starr MS. Disordered dopamine neurotransmission in the striatum of rats undergoing pilocarpine-induced generalized seizures, as revealed by microdialysis. Journal of Neural Transmission. Parkinson's Disease and Dementia Section. 5: 89-100. PMID 8101446 DOI: 10.1007/BF02251199  0.352
1993 Alam AM, Starr MS. Dopaminergic modulation of pilocarpine-induced motor seizures in the rat: the role of hippocampal D2 receptors. Neuroscience. 53: 425-31. PMID 8098511 DOI: 10.1016/0306-4522(93)90206-U  0.306
1993 Starr MS, Starr BS. Glutamate antagonists modify the motor stimulant actions of D1 and D2 agonists in reserpine-treated mice in complex ways that are not predictive of their interactions with the mixed D1/D2 agonist apomorphine. Journal of Neural Transmission. Parkinson's Disease and Dementia Section. 6: 215-26. PMID 7907216 DOI: 10.1007/BF02260924  0.435
1993 Starr MS, Starr BS. Glutamate-dopamine interactions in the production of pilocarpine motor seizures in the mouse. Journal of Neural Transmission. Parkinson's Disease and Dementia Section. 6: 109-17. PMID 7906944 DOI: 10.1007/BF02261004  0.39
1993 Starr MS, Starr BS. Facilitation of dopamine D1 receptor- but not dopamine D1/D2 receptor-dependent locomotion by glutamate antagonists in the reserpine-treated mouse. European Journal of Pharmacology. 250: 239-46. PMID 7906652 DOI: 10.1016/0014-2999(93)90387-W  0.451
1993 Alam AM, Starr MS. D1 agonists suppress zero Mg(2+)-induced epileptiform activity in the rat cingulate cortex slice. Neuroreport. 5: 78-80. PMID 7506591 DOI: 10.1097/00001756-199310000-00021  0.365
1992 Goodwin P, Starr BS, Starr MS. Motor responses to dopamine D1 and D2 agonists in the reserpine-treated mouse are affected differentially by the NMDA receptor antagonist MK 801. Journal of Neural Transmission. Parkinson's Disease and Dementia Section. 4: 15-26. PMID 1531757 DOI: 10.1007/BF02257618  0.437
1992 Alam AM, Starr MS. Dopaminergic modulation of pilocarpine-induced motor seizures in the rat: the role of hippocampal dopamine D1 receptors. European Journal of Pharmacology. 222: 227-32. PMID 1451735 DOI: 10.1016/0014-2999(92)90860-7  0.394
1992 Isaac L, Mills R, Fowler LJ, Starr BS, Starr MS. Putative neurotoxicity of SKF 38393 and other D1 dopaminergic drugs investigated in rat striatum. Journal of Neurochemistry. 58: 1464-8. PMID 1347781 DOI: 10.1111/j.1471-4159.1992.tb11365.x  0.322
1991 al-Tajir G, Starr MS. D-2 agonists protect rodents against pilocarpine-induced convulsions by stimulating D-2 receptors in the striatum, but not in the substantia nigra. Pharmacology, Biochemistry, and Behavior. 39: 109-13. PMID 1924492 DOI: 10.1016/0091-3057(91)90405-Q  0.383
1991 al-Tajir G, Starr MS. Anticonvulsant effect of striatal dopamine D2 receptor stimulation: dependence on cortical circuits? Neuroscience. 43: 51-7. PMID 1681459 DOI: 10.1016/0306-4522(91)90416-L  0.332
1991 Abbott B, Starr BS, Starr MS. CY 208-243 behaves as a typical D-1 agonist in the reserpine-treated mouse. Pharmacology, Biochemistry, and Behavior. 38: 259-63. PMID 1676166 DOI: 10.1016/0091-3057(91)90275-7  0.426
1990 al-Tajir G, Starr MS, Starr BS. Proconvulsant effect of SKF 38393 mediated by nigral D1 receptors. European Journal of Pharmacology. 182: 245-51. PMID 2204536 DOI: 10.1016/0014-2999(90)90283-C  0.422
1990 Chandler CJ, Starr BS, Starr MS. Differential behavioural interactions between the dopamine D-1 antagonist SCH 23390 and the dopamine D-2 antagonists metoclopramide and sulpiride in nonhabituated mice. Pharmacology, Biochemistry, and Behavior. 35: 285-9. PMID 2181484 DOI: 10.1016/0091-3057(90)90157-D  0.422
1990 Chandler CJ, Wohab W, Starr BS, Starr MS. Motor depression: a new role for D1 receptors? Neuroscience. 38: 437-45. PMID 2148204 DOI: 10.1016/0306-4522(90)90040-B  0.367
1990 al-Tajir G, Starr MS. Anticonvulsant action of SCH 23390 in the striatum of the rat. European Journal of Pharmacology. 191: 329-36. PMID 1982269 DOI: 10.1016/0014-2999(90)94165-T  0.375
1990 Burke K, Chandler CJ, Starr BS, Starr MS. Seizure promotion and protection by D-1 and D-2 dopaminergic drugs in the mouse. Pharmacology, Biochemistry, and Behavior. 36: 729-33. PMID 1977176 DOI: 10.1016/0091-3057(90)90068-S  0.35
1990 al-Tajir G, Chandler CJ, Starr BS, Starr MS. Opposite effects of stimulation of D1 and D2 dopamine receptors on the expression of motor seizures in mouse and rat. Neuropharmacology. 29: 657-61. PMID 1974713 DOI: 10.1016/0028-3908(90)90027-O  0.4
1989 Starr MS, Starr BS. Behavioural synergism between the dopamine agonists SKF 38393 and LY 171555 in dopamine-depleted mice: antagonism by sulpiride reveals only stimulant postsynaptic D-2 receptors. Pharmacology, Biochemistry, and Behavior. 33: 41-4. PMID 2571171 DOI: 10.1016/0091-3057(89)90426-7  0.399
1989 Fletcher GH, Starr MS. Differential effects of pallidal lesions on the behavioural responses to SKF 38393, LY 171555 and apomorphine in the rat. Neuroscience. 28: 171-80. PMID 2569694 DOI: 10.1016/0306-4522(89)90241-8  0.343
1988 Starr MS. D-1/D-2 behavioural interactions in the rat involving striatal dopamine D-1 receptors. European Journal of Pharmacology. 151: 479-82. PMID 3265106 DOI: 10.1016/0014-2999(88)90547-X  0.4
1988 Fletcher GH, Starr MS. Intracerebral SCH 23390 and catalepsy in the rat. European Journal of Pharmacology. 149: 175-8. PMID 2899514 DOI: 10.1016/0014-2999(88)90059-3  0.311
1987 Fletcher GH, Starr MS. Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours. Neuroscience. 23: 1001-10. PMID 2963970 DOI: 10.1016/0306-4522(87)90175-8  0.401
1987 Starr BS, Starr MS, Kilpatrick IC. Behavioural role of dopamine D1 receptors in the reserpine-treated mouse. Neuroscience. 22: 179-88. PMID 2957609 DOI: 10.1016/0306-4522(87)90208-9  0.404
1987 Starr M. Opposing roles of dopamine D1 and D2 receptors in nigral gamma-[3H]aminobutyric acid release? Journal of Neurochemistry. 49: 1042-9. PMID 2957468 DOI: 10.1111/J.1471-4159.1987.Tb09992.X  0.397
1987 Starr BS, Starr MS. Behavioural interactions involving D1 and D2 dopamine receptors in non-habituated mice. Neuropharmacology. 26: 613-9. PMID 2955244 DOI: 10.1016/0028-3908(87)90155-9  0.341
1987 Fletcher GH, Starr MS. Topography of dopamine behaviours mediated by D1 and D2 receptors revealed by intrastriatal injection of SKF 38393, lisuride and apomorphine in rats with a unilateral 6-hydroxydopamine-induced lesion. Neuroscience. 20: 589-97. PMID 2953990 DOI: 10.1016/0306-4522(87)90112-6  0.329
1986 Starr BS, Starr MS. Differential effects of dopamine D1 and D2 agonists and antagonists on velocity of movement, rearing and grooming in the mouse. Implications for the roles of D1 and D2 receptors. Neuropharmacology. 25: 455-63. PMID 3488514 DOI: 10.1016/0028-3908(86)90168-1  0.389
1986 Starr BS, Starr MS. Grooming in the mouse is stimulated by the dopamine D1 agonist SKF 38393 and by low doses of the D1 antagonist SCH 23390, but is inhibited by dopamine D2 agonists, D2 antagonists and high doses of SCH 23390. Pharmacology, Biochemistry, and Behavior. 24: 837-9. PMID 2940604 DOI: 10.1016/0091-3057(86)90421-1  0.327
1985 Fletcher GH, Starr MS. SKF 38393 and apomorphine modify locomotion and exploration in rats placed on a holeboard by separate actions at dopamine D-1 and D-2 receptors. European Journal of Pharmacology. 117: 381-5. PMID 3878300 DOI: 10.1016/0014-2999(85)90014-7  0.385
1981 Kilpatrick IC, Starr MS. Involvement of dopamine in circling responses to muscimol depends on intranigral site of injection. European Journal of Pharmacology. 69: 407-19. PMID 6265225 DOI: 10.1016/0014-2999(81)90444-1  0.351
Show low-probability matches.